β-Nicotinamide Mononucleotide (NMN) Administrated by Intraperitoneal Injection Mediates Protection Against UVB-Induced Skin Damage in Mice

β-Nicotinamide Mononucleotide (NMN) Administrated by Intraperitoneal Injection Mediates Protection Against UVB-Induced Skin Damage in Mice

Article Summary: The Protective Effects of Nicotinamide Mononucleotide on UVB-Induced Skin Damage in Mice

Introduction

Ultraviolet light causes skin oxidation, inflammation, and diseases

Nicotinamide mononucleotide (NMN) has anti-oxidation effects and improves physiological processes

Study on NMN's Protective Effect

  • Research explores the protective effect of NMN on UVB-induced photodamage
  • NMN treatment blocks UVB-induced photodamage in mice
  • NMN maintains normal skin structure, collagen fibers, and skin thickness
  • NMN reduces production of inflammatory mast cells
  • NMN maintains normal liver morphology after UVB exposure

Mechanisms of NMN's Effect

  • NMN increases antioxidant ability and regulates proinflammatory response to UVB irradiation
  • NMN activates AMPK signaling pathway and increases expression of downstream antioxidant genes
  • NMN downregulates expression of inflammatory cytokines and inhibits activation of NFκB-p65

Experimental Design and Results

  • NMN administered through intraperitoneal injection protects against UVB-induced skin damage
  • Histomorphological techniques, biochemical analysis, and gene/protein expression analysis were used
  • NMN improves liver and skin structure, oxidative stress indicators, and inflammatory markers

Conclusion and Future Research

NMN has a protective effect on UVB-induced skin damage in mice

NMN regulates oxidation and inflammation through signal pathways like NF-κB and AMPK

NMN administration could be further studied for its potential applications

Funding

Research was funded by various sources in China

Data Sharing and Ethics

  • All data generated or analyzed during the study are included in the article
  • Access to the datasets can be obtained from the corresponding author
  • The study protocol was approved by the Ethics Committee, ensuring animal welfare

Conflicts of Interest

The authors declare no conflicts of interest

Note: The headings provided in this summary are not an exhaustive representation of all the information in the article, but rather a synthesis of the main points covered.

Title of paper: β-Nicotinamide Mononucleotide (NMN) Administrated by Intraperitoneal Injection Mediates Protection Against UVB-Induced Skin Damage in Mice

Author(s): Zhou X, Du HH, Long X, Pan Y, Hu J, Yu J, Zhao X.

Year published: 2021

Published in: J Inflamm Res

Original article can be found here.

Back to blog

Looking For A 99% Pure NMN Supplement?

Reversal NMN is tested and verified by a third party lab. Trusted by many. Delivered worldwide via DHL Express.

Frequently Asked Questions (FAQ'S)